Park Jeffrey G 4

What Happened

• Jeffrey G. Park, a director of Progyny, received awards on May 21, 2026 totaling 44,587 shares (aggregate of three items reported). The grant includes a 7,924-share award (recorded at $0.00), a 5,205-share derivative option with an exercise price of $12.49 (reported value ~$65,010), and a 31,458-share award recorded as a derivative (reported at $0.00). These were reported on a Form 4 filed May 26, 2026. These grants are compensation (awards/options), not open-market purchases or sales.

Key Details

• Transaction date: May 21, 2026; Form 4 filed: May 26, 2026.
• Items reported: 7,924 shares @ $0.00 (acquired); 5,205 shares @ $12.49 (derivative/option, ~$65,010); 31,458 shares @ $0.00 (derivative).
• Vesting: Awards/options vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately before the Issuer's first annual meeting after the grant date, subject to continued service (see footnotes F1–F3).
• Option context: The 5,205-share option was issued in lieu of an annual cash retainer (~$64,985) for board/committee service (footnote F2).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Filing timeliness: Form 4 reflects the May 21 transaction and was filed May 26, 2026 (see official filing for any late-reporting notes).

Context

• RSUs and similar awards are compensation: RSUs represent a contingent right to receive shares upon vesting; options give the holder the right to buy shares at the exercise price ($12.49 here) and are not the same as an immediate purchase. These grants are routine director compensation rather than an expression of a buy/sell trading decision.